Hedge Fund - OrbiMed Advisors
Abbvie Inc. (ABBV)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $0 | 0% | 0 | $145.79 |
| 2 | 2023 - Q3 (2023-09-30) | $49,189,800 | 1.04% | 330,000 | $146.80 |
| 3 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $153.33 |
| 4 | 2022 - Q3 (2022-09-30) | $80,526,000 | 1.49% | 600,000 | $143.50 |
| 5 | 2022 - Q2 (2022-06-30) | $122,497,000 | 2.21% | 799,800 | $152.80 |
| 6 | 2022 - Q1 (2022-03-31) | $148,428,000 | 2.4% | 915,600 | $145.26 |
| 7 | 2021 - Q4 (2021-12-31) | $144,716,000 | 1.86% | 1,068,800 | $118.13 |
| 8 | 2021 - Q3 (2021-09-30) | $153,240,000 | 1.68% | 1,420,600 | $114.27 |
| 9 | 2021 - Q2 (2021-06-30) | $131,507,000 | 1.33% | 1,167,500 | $112.62 |
| 10 | 2021 - Q1 (2021-03-31) | $131,293,000 | 1.22% | 1,213,200 | $106.96 |
| 11 | 2020 - Q4 (2020-12-31) | $92,395,000 | 0.8% | 862,300 | $96.10 |
| 12 | 2020 - Q3 (2020-09-30) | $40,642,000 | 0.51% | 464,000 | $94.15 |
| 13 | 2020 - Q2 (2020-06-30) | $45,556,000 | 0.64% | 464,000 | $88.05 |
| 14 | 2020 - Q1 (2020-03-31) | $17,448,000 | 0.29% | 229,000 | $85.18 |
| 15 | 2018 - Q2 (2018-06-30) | $0 | 0% | 0 | $97.66 |
| 16 | 2018 - Q1 (2018-03-31) | $144,578,000 | 1.79% | 1,527,500 | $109.85 |
| 17 | 2017 - Q4 (2017-12-31) | $101,604,000 | 1.28% | 1,050,600 | $94.25 |
| 18 | 2017 - Q3 (2017-09-30) | $174,610,000 | 1.66% | 1,965,000 | $76.12 |
| 19 | 2017 - Q2 (2017-06-30) | $159,348,000 | 1.67% | 2,197,600 | $67.23 |
| 20 | 2017 - Q1 (2017-03-31) | $135,533,000 | 1.53% | 2,080,000 | $62.87 |
| 21 | 2016 - Q4 (2016-12-31) | $183,164,000 | 2.33% | 2,925,000 | $61.04 |
| 22 | 2016 - Q3 (2016-09-30) | $266,780,000 | 3.03% | 4,229,900 | $64.74 |
| 23 | 2016 - Q2 (2016-06-30) | $406,941,000 | 4.24% | 6,573,100 | $60.93 |
| 24 | 2016 - Q1 (2016-03-31) | $422,442,000 | 4.44% | 7,395,700 | $55.74 |
| 25 | 2015 - Q4 (2015-12-31) | $441,249,000 | 3.99% | 7,448,500 | $57.60 |
| 26 | 2015 - Q3 (2015-09-30) | $377,780,000 | 3.81% | 6,943,200 | $65.09 |
| 27 | 2015 - Q2 (2015-06-30) | $447,821,000 | 3.74% | 6,665,000 | $65.28 |
| 28 | 2015 - Q1 (2015-03-31) | $281,864,000 | 2.4% | 4,814,900 | $60.41 |
| 29 | 2014 - Q4 (2014-12-31) | $348,867,000 | 3.33% | 5,331,100 | $63.04 |
| 30 | 2014 - Q3 (2014-09-30) | $316,409,000 | 3.3% | 5,478,000 | $55.52 |
| 31 | 2014 - Q2 (2014-06-30) | $293,725,000 | 3.44% | 5,204,200 | $52.46 |
| 32 | 2014 - Q1 (2014-03-31) | $246,401,000 | 3.03% | 4,793,800 | $50.54 |
| 33 | 2013 - Q4 (2013-12-31) | $198,613,000 | 2.91% | 3,760,900 | $49.15 |
| 34 | 2013 - Q3 (2013-09-30) | $77,920,000 | 1.39% | 1,742,000 | $44.33 |
| 35 | 2013 - Q2 (2013-06-30) | $73,461,000 | 1.55% | 1,777,000 | $43.74 |
| 36 | 2013 - Q1 (2013-03-31) | $82,376,000 | 1.91% | 2,020,000 | $37.02 |
The displayed share prices are average quarterly stock market prices.